Hepatitis B vaccine: helping or hurting public health? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, May 18, 1999
What people are saying - Write a review
We haven't found any reviews in the usual places.
Hearing held on May 18 1999 1
Letters statements et cetera submitted for the record
Thiel Thelma chairman and CEO Hepatitis Foundation International
Other editions - View all
Academy of Pediatrics ACIP adults adverse reactions American Academy association autoimmune diseases Barbara Loe Fisher blood cause Center Chairman child chronically infected cirrhosis Classen clinical Committee Criminal Justice deaths developed diabetes doctor DPT vaccine Drug Policy effective ELLENBERG experience funds going groups HB vaccine HBV infection hearing hepatitis B immunization hepatitis B infection hepatitis B vaccine hepatitis B virus HEPB Initiative high risk Human Resources immunization program infants investigation Katz liver cancer liver disease MARGOLIS MICA million MlCA monkey multiple sclerosis occur parents patients percent physicians plaques polio vaccine potential prevent problems protect public health received recommendations scientific SCMV serious SIDS student studies Subcommittee on Criminal tested testimony thai Thank TIERNEY transmission United universal hepatitis vaccination programs vaccine adverse Vaccine Injury vaccine safety Vaccine Safety Datalink viruses Waisbren WAXMAN World Health Organization